Genexine, Inc. (KOSDAQ:095700)

Genexine Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 30, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	235,585	410,353	470,211	1,459,198	3,069,933	1,485,081
Market Cap Growth	-6.52%	-12.73%	-67.78%	-52.47%	106.72%	1227.62%
Enterprise Value	251,749	402,586	527,984	1,478,119	3,072,402	1,489,566
Last Close Price	5180.00	9900.00	14384.62	42410.56	90422.51	45465.87
PE Ratio	-	-	-	-	111.35	-
PS Ratio	40.56	92.70	29.14	39.62	165.55	131.39
PB Ratio	0.82	1.38	1.70	2.81	5.72	5.00
P/TBV Ratio	0.82	1.39	1.74	2.86	5.78	5.08
EV/Sales Ratio	43.35	90.95	32.72	40.14	165.69	131.78
Debt / Equity Ratio	0.24	0.23	0.30	0.10	0.05	0.13
Asset Turnover	0.01	0.01	0.03	0.06	0.04	-
Quick Ratio	1.05	1.41	0.42	0.51	0.37	3.82
Current Ratio	1.29	1.69	0.66	0.74	0.51	4.23
Return on Equity (ROE)	-17.31%	-23.28%	-14.26%	-9.26%	6.61%	-
Return on Assets (ROA)	-6.70%	-6.85%	-4.11%	-1.93%	-5.12%	-
Return on Capital (ROIC)	-6.98%	-7.22%	-4.51%	-2.10%	-5.44%	-
Earnings Yield	-23.14%	-16.30%	-11.90%	-3.29%	0.90%	-1.11%
FCF Yield	-17.96%	-11.05%	-15.22%	-4.74%	-1.46%	-3.07%
Buyback Yield / Dilution	-21.23%	-24.01%	-0.73%	-2.14%	-14.41%	-103.15%

Updated May 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.